Donghui Kan

Author PubWeight™ 56.01‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet 2009 6.91
2 Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility. Nat Genet 2009 5.06
3 Delay of surgery in men with low risk prostate cancer. J Urol 2011 3.05
4 Genome scan among Nigerians linking blood pressure to chromosomes 2, 3, and 19. Hypertension 2002 2.89
5 Can prostate specific antigen velocity thresholds decrease insignificant prostate cancer detection? J Urol 2010 2.35
6 Multiple elements regulate nuclear/cytoplasmic shuttling of FOXO1: characterization of phosphorylation- and 14-3-3-dependent and -independent mechanisms. Biochem J 2004 2.02
7 A combined analysis of genomewide linkage scans for body mass index from the National Heart, Lung, and Blood Institute Family Blood Pressure Program. Am J Hum Genet 2002 1.87
8 Prostate-specific antigen velocity (PSAV) risk count improves the specificity of screening for clinically significant prostate cancer. BJU Int 2012 1.68
9 Correlation between serum prostate-specific antigen and cancer volume in prostate glands of different sizes. Urology 2010 1.64
10 Treatment outcomes of radical prostatectomy in potential candidates for 3 published active surveillance protocols. Urology 2009 1.62
11 An association study of angiotensinogen polymorphisms with serum level and hypertension in an African-American population. J Hypertens 2003 1.44
12 [-2]Proenzyme prostate specific antigen is more accurate than total and free prostate specific antigen in differentiating prostate cancer from benign disease in a prospective prostate cancer screening study. J Urol 2010 1.40
13 A genome-wide scan for obesity in African-Americans. Diabetes 2002 1.25
14 A genome-wide linkage and association study using COGA data. BMC Genet 2005 1.14
15 Prostate specific antigen assay standardization bias could affect clinical decision making. J Urol 2008 1.12
16 Associations between hypertension and genes in the renin-angiotensin system. Hypertension 2003 1.09
17 Is statin use associated with prostate cancer aggressiveness? BJU Int 2009 1.09
18 Genetic prostate cancer risk assessment: common variants in 9 genomic regions are associated with cumulative risk. J Urol 2010 1.08
19 Combined analysis of genomewide scans for adult height: results from the NHLBI Family Blood Pressure Program. Eur J Hum Genet 2003 1.03
20 Angiotensin I-converting enzyme polymorphisms, ACE level and blood pressure among Nigerians, Jamaicans and African-Americans. Eur J Hum Genet 2004 1.02
21 Outcomes of radical prostatectomy for patients with clinical stage T1a and T1b disease. BJU Int 2009 0.99
22 An updated meta-analysis of genome scans for hypertension and blood pressure in the NHLBI Family Blood Pressure Program (FBPP). Am J Hypertens 2006 0.95
23 External validation of the cancer of the prostate risk assessment (CAPRA) score in a single-surgeon radical prostatectomy series. Urol Oncol 2010 0.94
24 Pathological outcomes associated with the 17q prostate cancer risk variants. J Urol 2009 0.94
25 Linkage for BMI at 3q27 region confirmed in an African-American population. Diabetes 2003 0.91
26 Prostate cancer risk alleles significantly improve disease detection and are associated with aggressive features in patients with a "normal" prostate specific antigen and digital rectal examination. Prostate 2010 0.90
27 Genetic effects on blood pressure localized to chromosomes 6 and 7. J Hypertens 2005 0.85
28 Erythrocyte sodium-lithium countertransport and blood pressure: a genome-wide linkage study. Hypertension 2002 0.84
29 Angiotensin-converting enzyme gene polymorphisms and obesity: an examination of three black populations. Obes Res 2005 0.84
30 A genome-wide scan of loci linked to serum adiponectin in two populations of African descent. Obesity (Silver Spring) 2007 0.83
31 Characteristics of prostate cancers detected at prostate specific antigen levels less than 2.5 ng/ml. J Urol 2009 0.83
32 Number of prostate cancer risk alleles may identify possibly 'insignificant' disease. BJU Int 2010 0.82
33 A genome scan among Nigerians linking resting energy expenditure to chromosome 16. Obes Res 2004 0.82
34 Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG. Prostate 2011 0.81
35 Summary of Genetic Analysis Workshop 15: Group 9 linkage analysis of the CEPH expression data. Genet Epidemiol 2007 0.80
36 Reducing blood loss in open radical retropubic prostatectomy with prophylactic periprostatic sutures. BJU Int 2009 0.80
37 Identifying genetic variation affecting a complex trait in simulated data: a comparison of meta-analysis with pooled data analysis. BMC Genet 2005 0.78
38 Preoperative prostate specific antigen doubling time is not a useful predictor of biochemical progression after radical prostatectomy. J Urol 2010 0.76
39 Does diabetes mellitus modify the association between 17q12 risk variant and prostate cancer aggressiveness? BJU Int 2009 0.75